NCT02604888

Brief Summary

The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Alopecia Areata.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 9, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 16, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

January 4, 2017

Status Verified

January 1, 2017

Enrollment Period

1 year

First QC Date

November 9, 2015

Last Update Submit

January 3, 2017

Conditions

Alopecia Areata

Keywords

BaldnessAlopecia AreataAlopeciaHair loss

Outcome Measures

Primary Outcomes (1)

  • Change of the Density of the Hair measured with a camera

    Change on the total amount of head's hair

    baseline and 180 days

Secondary Outcomes (1)

  • Change of the Amount of Hair Loss

    baseline and 180 days

Study Arms (1)

Volunteers

OTHER

20 volunteers both men and women with an age between 18 and 70 years suffering from Alopecia Areata in several types apply on the scalp drops of the MEXIS/M6S PATENT - lotion against Alopecia

Other: MEXIS/M6S Patent - lotion against alopecia

Interventions

MEXIS/M6S Patent - lotion against alopeciaOTHER

For greatest problems 20 drops on the scalp per day for 6 months. For minor problems 10 drops on the scalp three times per week for 6 months.

Volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Good state of general health
  • Suffering from Alopecia Areata
  • No pharmacological treatment in progress
  • Promise not to change the usual daily routine
  • No atopy in the anamnesis

You may not qualify if:

  • Illness
  • Good state of hair
  • Pharmacological treatment in progress
  • Denial of the continuance of the usual daily routine
  • Atopy in the anamnesis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

George Mexis

Athens, 11253, Greece

RECRUITING

MeSH Terms

Conditions

Alopecia AreataAlopecia

Condition Hierarchy (Ancestors)

HypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Markos Papakonstantis, Monitor

    401 General Military Hospital of Athens, Dermatology clinic

    STUDY CHAIR

Central Study Contacts

Sandy Matzakoni, Controller

CONTACT

info@mexis.gr

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2015

First Posted

November 16, 2015

Study Start

October 1, 2015

Primary Completion

October 1, 2016

Study Completion

October 1, 2017

Last Updated

January 4, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will share

Locations

GR(1)